Evidence map›Paper›PMID 25122782›Full record

ArticleJournal of virology2014

Probing the functions of the paramyxovirus glycoproteins F and HN with a panel of synthetic antibodies.

Brett D Welch, Marcin Paduch, George P Leser, Zachary Bergman, Christopher A Kors, Reay G Paterson, Theodore S Jardetzky, Anthony A Kossiakoff, Robert A Lamb

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Antivirals targeting paramyxovirus membrane fusion.Current opinion in virology · 2021
    Review
  7. Article
  8. Review
  9. Immobilization of the N-terminal helix stabilizes prefusion paramyxovirus fusion proteins.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Brett D WelchDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois, USA Howard Hughes Medical Institute, Northwestern University, Evanston, Illinois, USA.
Marcin PaduchDepartment of Biochemistry and Molecular Biology and the Institute for Biophysical Dynamics, The University of Chicago, Chicago, Illinois, USA.
George P LeserDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois, USA Howard Hughes Medical Institute, Northwestern University, Evanston, Illinois, USA.
Zachary BergmanDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois, USA.
Christopher A KorsDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois, USA Howard Hughes Medical Institute, Northwestern University, Evanston, Illinois, USA.
Reay G PatersonDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois, USA.
Theodore S JardetzkyDepartment of Structural Biology, Stanford University School of Medicine, Stanford, California, USA.
Anthony A KossiakoffDepartment of Biochemistry and Molecular Biology and the Institute for Biophysical Dynamics, The University of Chicago, Chicago, Illinois, USA koss@bsd.uchicago.edu ralamb@northwestern.edu.
Robert A LambDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois, USA Howard Hughes Medical Institute, Northwestern University, Evanston, Illinois, USA koss@bsd.uchicago.edu ralamb@northwestern.edu.
Northwestern University · USUniversity of Chicago · USHoward Hughes Medical Institute · USStanford University · US

Funding

Foreign - Univ. of Toronto, PI-Dr. Sachdev SidhuU01GM094588 · NIGMS · UNIVERSITY OF CHICAGO · PI KOSSIAKOFF, ANTHONY A · 2010 to 2014
$6.8M
STRUCTURAL STUDIES OF PARAMYXOVIRUS FUSION PROTEINSR01GM061050 · NIGMS · STANFORD UNIVERSITY · PI JARDETZKY, THEODORE S · 2000 to 2015
$3.1M
STRUCTURE &EXPRESSION OF THE PARAMYXOVIRUS SV5 GENOMER01AI023173 · NIAID · NORTHWESTERN UNIVERSITY · PI LAMB, ROBERT A · 1986 to 2010
$3.1M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI023173NIAID NIH HHS R01 AI-23173NIGMS NIH HHS R01 GM061050NIGMS NIH HHS U01 GM094588NIGMS NIH HHS U01GM094588
6 · The paper itself

Abstract

Paramyxoviruses are enveloped negative-strand RNA viruses that are significant human and animal pathogens. Most paramyxoviruses infect host cells via the concerted action of a tetrameric attachment protein (variously called HN, H, or G) that binds either sialic acid or protein receptors on target cells and a trimeric fusion protein (F) that merges the viral envelope with the plasma membrane at neutral pH. F initially folds to a metastable prefusion conformation that becomes activated via a cleavage event during cellular trafficking. Upon receptor binding, the attachment protein, which consists of a globular head anchored to the membrane via a helical tetrameric stalk, triggers a major conformation change in F which results in fusion of virus and host cell membranes. We recently proposed a model for F activation in which the attachment protein head domains move following receptor binding to expose HN stalk residues critical for triggering F. To test the model in the context of wild-type viral glycoproteins, we used a restricted-diversity combinatorial Fab library and phage display to rapidly generate synthetic antibodies (sAbs) against multiple domains of the paramyxovirus parainfluenza 5 (PIV5) pre- and postfusion F and HN. As predicted by the model, sAbs that bind to the critical F-triggering region of the HN stalk do not disrupt receptor binding or neuraminidase (NA) activity but are potent inhibitors of fusion. An inhibitory prefusion F-specific sAb recognized a quaternary antigenic site and may inhibit fusion by preventing F refolding or by blocking the F-HN interaction. Importance: The paramyxovirus family of negative-strand RNA viruses cause significant disease in humans and animals. The viruses bind to cells via their receptor binding protein and then enter cells by fusion of their envelope with the host cell plasma membrane, a process mediated by a metastable viral fusion (F) protein. To understand the steps in viral membrane fusion, a library of synthetic antibodies to F protein and the receptor binding protein was generated in bacteriophage. These antibodies bound to different regions of the F protein and the receptor binding protein, and the location of antibody binding affected different processes in viral entry into cells.

Indexed as

AnimalsAntibodiesAntibody SpecificityAntigens, ViralCell LineElectrophoresis, Polyacrylamide GelEnzyme-Linked Immunosorbent AssayGlycoproteinsHumansMicroscopy, ElectronParamyxoviridaeViral ProteinsAntibodiesAntigens, ViralGlycoproteinsViral Proteins

Identifiers

PMID25122782
PMCPMC4178754
OpenAlexW2169001273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.